Digestive Disease Interventions
DOI: 10.1055/a-2755-6966
Review Article

Increased Tumor Size on Angio-CT during Yttrium-90 Compared to Preprocedural Cross-sectional Imaging Studies

Authors

  • Qian Yu

    1   Department of Radiology, Vascular and Interventional Radiology, University of Chicago Medical Center, University of Chicago, Chicago, Illinois
  • Mikin Patel

    1   Department of Radiology, Vascular and Interventional Radiology, University of Chicago Medical Center, University of Chicago, Chicago, Illinois
  • Osman Ahmed

    1   Department of Radiology, Vascular and Interventional Radiology, University of Chicago Medical Center, University of Chicago, Chicago, Illinois

Funding None.

Abstract

Purpose

To evaluate changes in liver tumor size between preprocedural cross-sectional imaging and intraprocedural angio-CT among patients undergoing transarterial radioembolization.

Methods

A total of 128 patients with 153 tumors (58 female, 45.3%; mean age: 64.9 ± 9.86 years) were retrospectively reviewed from January 1, 2021, to December 31, 2023. Baseline patient characteristics and tumor sizes were collected. Radiologic response and progression-free survival (PFS) were analyzed. Statistical analysis was performed using STATA 18.0 (StataCorp, College Station, Texas).

Results

The average tumor size increased on angio-CT compared to preprocedural imaging (4.97 ± 2.98 cm vs. 4.55 ± 2.97 cm, p < 0.0001) over a time interval of 37.29 ± 27.70 days, with an average change of 0.42 ± 0.62 cm. Tumors with a delay of more than 1 month between preprocedural imaging and angio-CT showed a greater increase in size (0.59 ± 0.66 cm vs. 0.21 ± 0.49 cm, p = 0.0001). Tumors with a 30% or greater interval size increase were associated with worse PFS (p = 0.0049).

Conclusion

Intraprocedural angio-CT can detect tumor growth during radioembolization mapping or administration. Tumor growth is most significant when there is a longer delay between preprocedural imaging and the procedure, and this growth correlates with PFS. Intraprocedural angio-CT provides critical prognostic information that can potentially influence treatment algorithms and should be regarded as a valuable component of interventional oncology procedures.



Publication History

Received: 04 June 2025

Accepted: 25 November 2025

Article published online:
07 January 2026

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA